Search
Cencora Inc
CORAdd to Watchlist
261.200USD
+5.540+2.17%
Close 05/08, 16:00（ET）Quotes delayed by 15 min
50.81BMarket Cap
19.92P/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+2.17%
5 Days
-15.20%
1 Month
-18.60%
6 Months
-27.59%
Year to Date
-22.66%
1 Year
-14.24%
TradingKey Stock Score of Cencora Inc
Currency: USD Updated: 2026-05-07Key Insights
Cencora Inc's fundamentals are relatively weak, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 44 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 376.59.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cencora Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Cencora Inc Highlights
StrengthsRisks
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 321.33B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 22.56% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 28.12%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 28.12%.
Undervalued
The company’s latest PE is 19.49, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 187.12M shares, decreasing 0.08% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 5.82K shares of this stock.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
376.586
Target Price
+49.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cencora Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cencora Inc Info
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Ticker SymbolCOR
CompanyCencora Inc
CEOMauch (Robert P)
Websitehttps://www.cencora.com/
Related Instruments
+2.72%
-2.00%
-0.76%
-3.11%
-2.58%
+3.64%
-2.96%
+1.38%
-2.33%
+1.30%
-4.65%
+1.41%
-3.40%
-2.08%
-2.52%
+11.26%
-2.57%
-5.55%
-2.08%Popular Instruments
92.193
-2.977 (-3.13%)
293.260
+5.820 (+2.02%)
215.160
+3.660 (+1.73%)
4714.280
+29.030 (+0.62%)
480.000
+16.090 (+3.47%)
1561.080
+221.120 (+16.50%)
747.000
+100.370 (+15.52%)
400.690
+2.700 (+0.68%)
80103.090
+253.100 (+0.32%)
428.380
+16.590 (+4.03%)
